Astria Therapeutics Inc. (ATXS)
6.03
-0.07 (-1.15%)
At close: Mar 04, 2025, 11:10 AM
Astria Therapeutics Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -72.89M | -51.83M | -194.91M | -37.3M | -26.29M | -25.87M | -27.36M | -36.06M | -32.63M | -21.88M | -18.12M | -15.67K |
| Depreciation & Amortization | n/a | n/a | n/a | n/a | 26K | 119K | 304K | 395K | 202K | 248K | 320K | 327.00 |
| Stock-Based Compensation | 6.31M | 4.55M | 3.36M | 1.39M | 1.51M | 1.77M | 2.01M | 2.16M | 1.66M | 897K | 343K | 196.00 |
| Other Working Capital | -3.14M | 3.41M | -1.34M | 3.02M | -1.66M | 100K | -1.3M | 197K | 488K | -228K | 1.22M | n/a |
| Other Non-Cash Items | 545K | 1.1M | 164.7M | 58K | 33K | 56K | 155K | 277K | 293K | 74K | 343K | -241 |
| Deferred Income Tax | n/a | n/a | n/a | n/a | 23K | -303K | -4K | 96K | n/a | n/a | -343K | n/a |
| Change in Working Capital | -2.41M | 2.65M | -3.31M | 3.37M | -1.87M | 762K | -1.93M | 274K | 684K | 253K | 1.09M | n/a |
| Operating Cash Flow | -68.44M | -43.53M | -30.15M | -32.48M | -26.57M | -23.46M | -26.84M | -32.86M | -29.79M | -20.41M | -16.37M | -15.58K |
| Capital Expenditures | -25K | -91K | -21K | -33K | -12K | 18K | -57K | -459K | -421K | -228K | -43K | -360 |
| Acquisitions | n/a | 167.04K | 6.47M | -6.33K | 4.07K | -18K | 45.54M | 52K | n/a | n/a | n/a | n/a |
| Purchase of Investments | -1.92B | -396.06M | -78M | -62.78M | -155.2M | -70.36M | -45.54M | -45.54M | n/a | -4.98M | n/a | n/a |
| Sales Maturities Of Investments | 2.06B | 229.03M | 59M | 69.11M | 151.13M | 48.09M | 14.91M | 30.46M | n/a | 4.98M | n/a | n/a |
| Other Investing Acitivies | n/a | -167.04K | -12.53K | 6.33K | -4.07K | 369K | 30K | 52K | n/a | n/a | n/a | n/a |
| Investing Cash Flow | 135.05M | -167.13M | -12.55M | 6.3M | -4.08M | -21.91M | 14.88M | -15.49M | -421K | -228K | -43K | -360 |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a | -2.85M | -3.33M | -3.33M | 4.17M | 5M | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 420K | 84K | 23K | 31K | 54K | 4K | 23K | 503K | 12.41M | -166K | 41.45M | n/a |
| Financial Cash Flow | 88.4M | 144.72M | 104.28M | 40.86M | 25.62M | 44.3M | 4.73M | 9.16M | 78.33M | 4.83M | 41.45M | 8.75K |
| Net Cash Flow | 155M | -65.94M | 61.58M | 14.68M | -5.03M | -1.07M | -7.23M | -39.18M | 48.11M | -15.81M | 25.04M | -7.2K |
| Free Cash Flow | -68.47M | -43.62M | -30.17M | -32.52M | -26.58M | -23.45M | -26.89M | -33.32M | -30.21M | -20.64M | -16.41M | -15.94K |